Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Brain : a journal of neurology

• Publication date

  2010-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/brain/awq158PMID 20576697
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emotion recognition in progressive supranuclear palsy

  2009cited by this paper
• Assessment of dementia in patients with multiple system atrophy

  2009cited by this paper
• Genetic Variants of the α-Synuclein Gene SNCA Are Associated with Multiple System Atrophy

  2009cited by this paper
• Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study

  2008influential reference
• Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes.

  2008cited by this paper
• Cognitive impairments in multiple system atrophy

  2008influential reference
• Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.

  2008influential reference
• Second consensus statement on the diagnosis of multiple system atrophy

  2008cited by this paper
• The Frontal Assessment Battery (FAB) in Parkinson’s disease and correlations with formal measures of executive functioning

  2008cited by this paper
• Clinical diagnostic criteria for dementia associated with Parkinson's disease

  2007cited by this paper
• Frontal presentation in progressive supranuclear palsy

  2007influential reference
• Cognitive function in multiple system atrophy of the cerebellar type

  2006cited by this paper
• Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.

  2006influential reference
• Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG)

  2006cited by this paper
• Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.

  2006cited by this paper
• Visuospatial functions in atypical parkinsonian syndromes

  2006cited by this paper
• Regional brain volumes distinguish PSP, MSA‐P, and PD: MRI‐based clinico‐radiological correlations

  2006cited by this paper
• Subcortical dementia revisited: Similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA)

  2005influential reference
• Cognitive bedside assessment in atypical parkinsonian syndromes

  2005influential reference
• The North American Multiple System Atrophy Study Group

  2005cited by this paper
• The European Multiple System Atrophy-Study Group (EMSA-SG)

  2005cited by this paper
• Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

  2005cited by this paper
• The Frontal Assessment Battery (FAB): normative values in an Italian population sample

  2005cited by this paper
• Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing

  2005influential reference
• Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank

  2003cited by this paper
• Clinical features and natural history of progressive supranuclear palsy

  2003cited by this paper
• Differentiation of parkinsonian syndromes according to differences in executive functions

  2003influential reference
• Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.

  2002cited by this paper
• Patterns of neuropsychological performance in multiple system atrophy compared to sporadic and hereditary olivopontocerebellar atrophy.

  2002cited by this paper
• The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.

  2001cited by this paper
• The FAB: A frontal assessment battery at bedside

  2001cited by this paper
• Epidemiology of progressive supranuclear palsy

  2001cited by this paper
• Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy

  2001cited by this paper
• Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.

  2001cited by this paper
• Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy

  2000cited by this paper
• The FAB: A frontal assessment battery at bedside

  2000cited by this paper
• What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?

  2000influential reference
• Consensus statement on the diagnosis of multiple system atrophy.

  1999cited by this paper
• Consensus statement on the diagnosis of multiple system atrophy

  1998cited by this paper
• Normative data for the Mattis Dementia Rating Scale.

  1998cited by this paper
• [Dementia rating scale].

  1997cited by this paper
• Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.

  1997cited by this paper
• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996influential reference
• Attentional functions in multiple system atrophy and Parkinson's disease.

  1996cited by this paper
• Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy

  1996cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.

  1994cited by this paper
• Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

  1994cited by this paper
• Cognitive and motor performance in multiple system atrophy and Parkinson's disease compared.

  1993cited by this paper
• Cognitive performance in multiple system atrophy.

  1992cited by this paper
• Neuropsychological deficits accompanying striatonigral degeneration.

  1991cited by this paper
• Memory impairment in patients with progressive supranuclear palsy.

  1989cited by this paper
• Cognitive differences between patients with progressive supranuclear palsy and Alzheimer's disease.

  1989cited by this paper
• Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease.

  1988cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease

  1986cited by this paper
• Recent Developments in Parkinson's Disease

  1986cited by this paper
• Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

  1985cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Book Review: Third Symposium on Parkinson's Disease

  1970cited by this paper
• Projection technique for evaluating surgery in Parkinson’s disease

  1969influential reference

• Dementia in Progressive Supranuclear Palsy: A Narrative Review.

  2026cites this paper
• Executive Dysfunction and Disability in SPMS: Predictive Value of the Frontal Assessment Battery in the UCLH MS‐STAT2 Cohort

  2025cites this paper
• Cognitive Performance in Parkinson's Spectrum Disorders: a comparative study of patients with Parkinson's Disease, Parkinson's Disease Dementia, Dementia With Lewy Bodies, Progressive Supranuclear Palsy, and Corticobasal Syndrome.

  2025cites this paper
• The Spectrum of Cognitive Impairment in Atypical Parkinsonism Syndromes: A Comprehensive Review of Current Understanding and Research

  2025influential citation
• Characteristics of cerebral glucose metabolism in patients with cognitive impairment in multiple system atrophy

  2025cites this paper
• Molecular imaging based spatiotemporal dynamics progression of brain glucose metabolism in multiple system atrophy

  2025cites this paper
• Differences in neuropsychological performance across clinical variants of progressive supranuclear palsy

  2025cites this paper
• Domain-specific brain regions are associated with cognitive impairment in progressive supranuclear palsy

  2025cites this paper
• Associations between neuropsychological profile and regional brain FDG uptake in progressive supranuclear palsy

  2025cites this paper
• Cognitive Dysfunction in Multi-system Atrophy

  2025cites this paper
• Comparing a BCI Communication System in a Patient with Multiple System Atrophy, with an animal model.

  2025cites this paper
• Verbal fluency is associated with Gait impairment in Progressive Supranuclear Palsy

  2025cites this paper
• A 15-Item modification of the PSP rating scale to improve clinical meaningfulness and statistical performance

  2025cites this paper
• Clinical and neuroimaging correlates of disease related gait patterns in patients with multiple system atrophy cerebellar type

  2025cites this paper
• Cognitive impairment in Parkinson’s disease and other parkinsonian syndromes

  2024cites this paper
• Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET

  2024cites this paper
• Rapid Cognitive Deterioration in Progressive Supranuclear Palsy: A 1‐Year Follow‐Up Study

  2024cites this paper
• Inhibition of midbrain cholinergic neurons impairs decision-making strategies during reversal learning

  2024cites this paper
• Relationships between Serum Lipid, Uric Acid Levels and Mild Cognitive Impairment in Parkinson's Disease and Multiple System Atrophy.

  2024cites this paper
• Synchronous monitoring of brain‐heart electrophysiology using heart rate variability coupled with rapid quantitative electroencephalography in orthostatic hypotension patients with α‐synucleinopathies: Rapid prediction of orthostatic hypotension and preliminary exploration of brain stimulation thera

  2024cites this paper
• Influence of cognitive reserve on cognitive and motor function in α-synucleinopathies: A systematic review and multilevel meta-analysis.

  2024cites this paper
• [Cognitive impairment in multiple system atrophy - exclusion criteria or an integral part of the clinical picture?]

  2024cites this paper
• “¿Cómo qué, cómo qué? cómo qué?” Single-language echolalia in a bilingual female with progressive supranuclear palsy: a case report

  2024cites this paper
• Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect

  2024influential citation
• A Systematic Review of the Spectrum and Prevalence of Non-motor Symptoms in Multiple System Atrophy

  2024cites this paper
• Impaired sequence manipulation in non‐demented patients with progressive supranuclear palsy

  2024cites this paper
• Characteristics of Anal Sphincter Electromyography in Patients with Multiple System Atrophy

  2023cites this paper
• Neuropathological analysis of cognitive impairment in progressive supranuclear palsy.

  2023cites this paper
• Pathomechanisms of cognitive impairment in progressive supranuclear palsy

  2023cites this paper
• Mild cognitive impairment in multiple system atrophy: a brain network disorder

  2023influential citation
• Association between Cognitive Impairment and Hippocampal Subfield Volumes in Multiple System Atrophy

  2023cites this paper
• Characteristics of Mild Cognitive Impairment and Associated Factors in MSA Patients

  2023influential citation
• Cognitive Impairment in Neurodegenerative Movement Disorders

  2023cites this paper
• Automatic classification of MSA subtypes using Whole-brain gray matter function and Structure-Based radiomics approach.

  2023cites this paper
• Motor assessment of patients with multiple system atrophy: underuse of the Unified Multiple System Atrophy Rating Scale (UMSARS)

  2023cites this paper
• Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease.

  2023cites this paper
• Structural correlates of survival in Progressive Supranuclear Palsy

  2023cites this paper
• Differential immunophenotypes of neuronal cytoplasmic inclusions in the dentate gyrus of multiple system atrophy and their association with clinicopathological features.

  2023cites this paper
• A case of the development of early mental and autonomic disorders in a patient with Parkinson's disease. differential diagnosis with atypical parkinsonism

  2023cites this paper
• Quantitative cellular changes in multiple system atrophy brains

  2023cites this paper
• Sentence completion in progressive supranuclear palsy following transcranial direct current stimulation

  2023cites this paper
• Waiting impulsivity in progressive supranuclear palsy-Richardson’s syndrome

  2023cites this paper
• Cognitive and Autonomic Dysfunction in Multiple System Atrophy Type P and C: A Comparative Study

  2022cites this paper
• The Cognitive Profile of Atypical Parkinsonism: A Meta-Analysis

  2022cites this paper
• Prevalence and Clinical Characteristics of Dementia and Cognitive Impairment in Multiple System Atrophy: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Alterations of voxel‐wise spontaneous activity and corresponding brain functional networks in multiple system atrophy patients with mild cognitive impairment

  2022cites this paper
• Morphological differences between the two major subtypes of multiple system atrophy with cognitive impairment.

  2022cites this paper
• Atrophie multisystématisée

  2022cites this paper
• Do Patients with Progressive Supranuclear Palsy Have Episodic Memory Impairment? A Systematic Review

  2022cites this paper
• The Frontal and Cerebellar Metabolism Related to Cognitive Dysfunction in Multiple System Atrophy

  2022cites this paper
• Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study

  2022cites this paper
• Atrofia multisistemica

  2022cites this paper
• Episodic memory in progressive supranuclear palsy: a neuropsychological and neuroimaging study

  2022cites this paper
• The size and behavior of virtual objects have influence on functional exercise and motivation of persons with multiple sclerosis: a randomized study

  2022cites this paper
• Association Between Orthostatic Hypotension and Dementia in Patients With Parkinson Disease and Multiple System Atrophy

  2022cites this paper
• Naming in Older Adults: Complementary Auditory and Visual Assessment

  2021cites this paper
• Dementia and Systemic Disease

  2021cites this paper
• Laboratory‐Supported Multiple System Atrophy beyond Autonomic Function Testing and Imaging: A Systematic Review by the MoDiMSA Study Group

  2021cites this paper
• [Neuropathology of dementia].

  2021cites this paper
• Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia.

  2021cites this paper
• Cerebral Metabolism Related to Cognitive Impairments in Multiple System Atrophy

  2021cites this paper
• Multiple System Atrophy

  2021cites this paper
• Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes

  2021cites this paper
• Quantitative cellular changes in the thalamus of patients with Multiple System Atrophy.

  2021cites this paper
• A Systematic Review of Apathy and Depression in Progressive Supranuclear Palsy

  2021cites this paper
• Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy

  2021cites this paper
• A study on the characteristics of cognitive function in patients with multiple system atrophy in China

  2021cites this paper
• Phonemic fluency quantity and quality: Comparing patients with PSP, Parkinson's disease and focal frontal and subcortical lesions.

  2021cites this paper
• Parkinsonism and dementia.

  2021cites this paper
• Development of a cognitive composite for measuring change in progressive supranuclear palsy.

  2021cites this paper
• Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study

  2021cites this paper
• Diagnostic, management and nursing challenges of less common dementias: Parkinsonian dementias and Huntington's disease

  2021cites this paper
• Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review

  2021cites this paper
• The role of noradrenaline in cognition and cognitive disorders

  2021cites this paper
• Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants

  2021cites this paper
• Neuropathologie der Demenzen

  2021cites this paper
• Spatial attention and spatial short term memory in PSP and Parkinson's disease.

  2021cites this paper
• Cognitive Impairment as an Unexpected Guest

  2020cites this paper
• An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention

  2020cites this paper
• Neuropathological findings in multiple system atrophy with cognitive impairment

  2020cites this paper
• Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies

  2020cites this paper
• Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study.

  2020cites this paper
• Evaluating Executive Functions in Patients with Juvenile Myoclonic Epilepsy Using Frontal Assessment Battery

  2020cites this paper
• Hippocampal α-synuclein pathology correlates with memory impairment in multiple system atrophy.

  2020cites this paper
• Kinetics of α-synuclein prions preceding neuropathological inclusions in multiple system atrophy

  2020cites this paper
• The Progressive Supranuclear Palsy Clinical Deficits Scale

  2020cites this paper
• Cognition in multiple system atrophy: a single‐center cohort study

  2020cites this paper
• Central auditory processing in Parkinsonian disorders: A systematic review.

  2020cites this paper
• Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series

  2020cites this paper
• The Profile and Evolution of Neuropsychiatric Symptoms in Multiple System Atrophy: Self- and Caregiver Report.

  2020cites this paper
• Cognitive Profile and Its Evolution in a Cohort of Multiple System Atrophy Patients

  2020cites this paper
• Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis

  2020cites this paper
• Multiple system atrophy - a clinicopathological update.

  2020cites this paper
• Association of orthostatic blood pressure with the symptoms of orthostatic hypotension and cognitive impairment in patients with multiple system atrophy.

  2020cites this paper
• Current Management and Emerging Therapies in Multiple System Atrophy

  2020cites this paper
• Multiple System Atrophy: Phenotypic spectrum approach coupled with brain 18-FDG PET.

  2019cites this paper
• Dichotomy between motor and cognitive functions of midbrain cholinergic neurons.

  2019cites this paper
• Cognitive impairment and structural brain damage in multiple system atrophy-parkinsonian variant

  2019cites this paper
• Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.

  2019cites this paper
• Evolution of neuropsychological profile in motor subtypes of multiple system atrophy.

  2019cites this paper